Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations

Mohammed Aboukaoud; Shoshana Israel; Chaim Brautbar; Sara Eyal

doi:10.1007/s11095-018-2472-8

Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations

Mohammed Aboukaoud, Shoshana Israel, Chaim Brautbar, Sara Eyal^*

^*Corresponding author for this work

School of Pharmacy

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

Genetic variation can affect drug pharmacokinetics and pharmacodynamics and contribute to variability between individuals in response to medications. Specifically, differences in allele frequencies among individuals and ethnic groups have been associated with variation in their propensity to develop drug hypersensitivity reactions (HSRs). This article reviews the current knowledge on the genetic background of HSRs and its relevance to Jewish and Arab populations. The focus is on human leukocyte antigen (HLA) alleles and haplotypes as predictive markers of HSRs (“immunopharmacogenetics”), but other genes and alleles are described as well. Also discussed is the translation of the pharmacogenetic information to practice recommendations.

Original language	English
Article number	211
Journal	Pharmaceutical Research
Volume	35
Issue number	11
DOIs	https://doi.org/10.1007/s11095-018-2472-8
State	Published - 1 Nov 2018

Bibliographical note

Publisher Copyright:
© 2018, Springer Science+Business Media, LLC, part of Springer Nature.

Keywords

Arab
Jewish
human leukocyte antigens
hypersensitivity reactions

Access to Document

10.1007/s11095-018-2472-8

Cite this

@article{ea0af5ef85ea40b8b7474b12e8d5cec3,

title = "Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations",

abstract = "Genetic variation can affect drug pharmacokinetics and pharmacodynamics and contribute to variability between individuals in response to medications. Specifically, differences in allele frequencies among individuals and ethnic groups have been associated with variation in their propensity to develop drug hypersensitivity reactions (HSRs). This article reviews the current knowledge on the genetic background of HSRs and its relevance to Jewish and Arab populations. The focus is on human leukocyte antigen (HLA) alleles and haplotypes as predictive markers of HSRs (“immunopharmacogenetics”), but other genes and alleles are described as well. Also discussed is the translation of the pharmacogenetic information to practice recommendations.",

keywords = "Arab, Jewish, human leukocyte antigens, hypersensitivity reactions",

author = "Mohammed Aboukaoud and Shoshana Israel and Chaim Brautbar and Sara Eyal",

note = "Publisher Copyright: {\textcopyright} 2018, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2018",

month = nov,

day = "1",

doi = "10.1007/s11095-018-2472-8",

language = "אנגלית",

volume = "35",

journal = "Pharmaceutical Research",

issn = "0724-8741",

publisher = "Springer",

number = "11",

}

TY - JOUR

T1 - Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations

AU - Aboukaoud, Mohammed

AU - Israel, Shoshana

AU - Brautbar, Chaim

AU - Eyal, Sara

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Genetic variation can affect drug pharmacokinetics and pharmacodynamics and contribute to variability between individuals in response to medications. Specifically, differences in allele frequencies among individuals and ethnic groups have been associated with variation in their propensity to develop drug hypersensitivity reactions (HSRs). This article reviews the current knowledge on the genetic background of HSRs and its relevance to Jewish and Arab populations. The focus is on human leukocyte antigen (HLA) alleles and haplotypes as predictive markers of HSRs (“immunopharmacogenetics”), but other genes and alleles are described as well. Also discussed is the translation of the pharmacogenetic information to practice recommendations.

AB - Genetic variation can affect drug pharmacokinetics and pharmacodynamics and contribute to variability between individuals in response to medications. Specifically, differences in allele frequencies among individuals and ethnic groups have been associated with variation in their propensity to develop drug hypersensitivity reactions (HSRs). This article reviews the current knowledge on the genetic background of HSRs and its relevance to Jewish and Arab populations. The focus is on human leukocyte antigen (HLA) alleles and haplotypes as predictive markers of HSRs (“immunopharmacogenetics”), but other genes and alleles are described as well. Also discussed is the translation of the pharmacogenetic information to practice recommendations.

KW - Arab

KW - Jewish

KW - human leukocyte antigens

KW - hypersensitivity reactions

UR - http://www.scopus.com/inward/record.url?scp=85053429558&partnerID=8YFLogxK

U2 - 10.1007/s11095-018-2472-8

DO - 10.1007/s11095-018-2472-8

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

C2 - 30225831

AN - SCOPUS:85053429558

SN - 0724-8741

VL - 35

JO - Pharmaceutical Research

JF - Pharmaceutical Research

IS - 11

M1 - 211

ER -

Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this